| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.041 | 0.3 |